PNNL offers a third-party testing environment to provide battery companies with independent data about their grid-scale systems.

McDermott is co-chairing one of only five organized sessions at the annual Pacific Symposium on Biocomputing.

PNNL researchers Daniel Deng and Yehia Ibrahim join the 2025 class of National Academy of Inventors Fellows.

For nearly 20 years, PNNL has invested in a multidisciplinary effort to develop better batteries.

GSL's utility-grade battery testing operation is now fully operational.

In a recent study, PNNL researchers found that noncrystalline mineral surfaces can bind microbial residues to build soil organic matter.

PNNL researchers are opening up a new front in the fight to stop viral pathogens, protecting people against multiple viruses.

Big energy storage science is brewing at GSL just one year after its groundbreaking.

Dušan Veličković, a PNNL mass spectrometry imaging scientist received a $2.1 million grant to develop techniques to understand how changes in carbohydrate structure affect human health.

Matt Fayette, a materials scientist, is testing a new method to extend battery life for grid storage by circulating the electrolyte.

PNNL has created and licensed a system that sniffs out trace levels of fentanyl, other drugs and explosives through the air.

Over the next four years, PNNL and University of Arizona will develop open-source computational tools to better identify and characterize the viruses associated with the human microbiome.

Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

Mini flow cell battery provides the first step toward an AI-driven, robotic energy storage discovery laboratory.

A potential quantum advantage for fluid dynamics simulations from molecular to atmospheric scales with a new formula for success.

Researchers developed a robust, cost-effective, and easy-to-use cap-based technique for spatial proteome mapping, addressing the lack of accessible proteomics technologies for studying tissue heterogeneity and microenvironments.

CACTUS provides AI-powered cheminformatics for autonomous science.

Scientists are using artificial intelligence and powerful computing to sculpt new molecules in an effort to treat disease.

University of Washington Professor David Baker won the 2024 Nobel Prize in Chemistry for computational protein design.

Scientists are developing ways to detect previously unseen forms of fentanyl as well as other synthetic opioids known as nitazenes.